Hoxton Ventures is an American venture capital firm investing in early-stage European technology companies.
Hoxton Ventures and Tiferes Ventures have led a seed investment in data analytics platform Fluent.
"On average, 40% of a data team’s time is spent answering questions from across their business. A lot of these questions are easy to answer for the data team but take them away from the deeper, more strategic analysis that can be transformative to their business. With Fluent’s natural language interface, we’re helping team members self-serve on their data questions."
Octopus Ventures led the Series A round with participation from Hoxton Ventures and Route66 Ventures.
"Diagnosing and treating ADHD can be a long and costly process, and living with the symptoms can be extremely challenging. We want to help our members make significant improvements to their quality of life by giving them the tools to better understand themselves, and implement coping strategies that actually work."
The round was led by F-Prime Capital to support the development of novel therapeutics for disordered proteins.
"By taking a rigorous and computer-driven experimental physics approach to analysing proteins, we can go beyond classical drug discovery approaches and observe protein behaviour that algorithms like AlphaFold cannot. This new funding will allow us to further advance our platform and support the investigation of the disordered protein universe towards developing drugs of the future,"
Hoxton Ventures led the Series A round to support international growth and product development.
"The pandemic has taught us that we cannot take air quality for granted, but airborne disease transmission is not the only reason to care about air quality"
The seed round was backed by Pear VC, Hoxton Ventures, Edison Partners, and the founders of DoorDash.
"The typical pharmacy experience has long been in need of an upgrade, and most pharmacists, despite being well trained and highly knowledgeable, are so bogged down by manual, repetitive tasks that they only have time to provide a basic, transactional service. Our mission is to provide a personalised pharmacy service for people who are on lots of medication that makes accessing the drugs and support they need a whole lot easier for them."
